Advertisement

Heart rate variability and baroreflex sensitivity abnormalities in Guillain–Barré syndrome: a pilot study

  • Cheng-Yin Tan
  • Nortina Shahrizaila
  • Kee-Ying Yeoh
  • Khean-Jin Goh
  • Maw-Pin Tan
Research Article

Abstract

Objective

The current study aimed to investigate autonomic dysfunction in Guillain–Barré syndrome (GBS) patients and describe the results of computational heart rate variability (HRV)/baroreflex sensitivity (BRS) and autonomic challenge tests.

Methods

GBS patients were consecutively recruited and the results were compared to age- and gender-matched healthy controls. A series of autonomic function tests including computation-dependent tests (power spectrum analysis of HRV and BRS at rest) and challenge maneuvers (deep breathing, eyeball compression, active standing, the Valsalva maneuver, sustained handgrip, and the cold pressor test) were performed.

Results

Ten GBS patients (six men; mean age = 40.1 ± 13.9 years) and ten gender- and age-matched healthy controls were recruited. The mean GBS functional grading scale at disease plateau was 3.4 ± 1.0. No patients required intensive care unit admission or mechanical ventilation. Low-frequency HRV (p = 0.027), high-frequency HRV (p = 0.008), and the total power spectral density of HRV (p = 0.015) were significantly reduced in patients compared to controls. The mean up slope (p = 0.034), down slope (p = 0.011), and total slope (p = 0.024) BRS were significantly lower in GBS patients. The diastolic rise in blood pressure in the cold pressor test was significantly lower in GBS patients compared to controls (p = 0.008).

Interpretation

Computation-dependent tests (HRV and BRS) were more useful for detecting autonomic dysfunction in GBS patients, whereas the cold pressor test was the only reliable challenge test, making it useful as a bedside measure of autonomic function in GBS patients.

Keywords

Guillain–Barré syndrome Autonomic dysfunction Autonomic function test Heart rate variability Baroreflex sensitivity 

Notes

Funding

This study was funded by a grant from the University of Malaya (Project no. BK074-2017).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10286_2018_525_MOESM1_ESM.docx (21 kb)
Supplementary material 1 (DOCX 20 kb)

References

  1. 1.
    Ropper AH (1992) The Guillain-Barré syndrome. N Eng J Med 326:1130–1136CrossRefGoogle Scholar
  2. 2.
    Alshekhlee A, Hussain Z, Sultan B, Katirji B (2008) Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology 70:1608–1613CrossRefPubMedGoogle Scholar
  3. 3.
    Lawn ND, Wijdicks EF (1999) Fatal Guillain-Barré syndrome. Neurology 52:635–638CrossRefPubMedGoogle Scholar
  4. 4.
    van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC (2013) Mortality in Guillain-Barré syndrome. Neurology 80:1650–1654CrossRefPubMedGoogle Scholar
  5. 5.
    Netto AB, Taly AB, Kulkarni GB, Rao UG, Rao S (2011) Mortality in mechanically ventilated patients of Guillain-Barré syndrome. Ann Indian Acad Neurol 14:262–266CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Ishaque T, Islam MB, Ara G, Endtz HP, Mohammad QD, Jacobs BC et al (2017) High mortality from Guillain-Barré syndrome in Bangladesh. J Peripher Nerv Syst 22(2):121–126CrossRefPubMedGoogle Scholar
  7. 7.
    Flachenecker P (2007) Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis. J Neurol 254:II96–II101CrossRefPubMedGoogle Scholar
  8. 8.
    Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) 285(6346):916–918CrossRefGoogle Scholar
  9. 9.
    Winer JB, Hughes RA (1988) Identification of patients at risk of arrhythmia in the Guillain-Barré syndrome. Q J Med 68:735–739PubMedGoogle Scholar
  10. 10.
    Wong AHY, Umapathi T, Shahrizaila N et al (2014) The value of comparing mortality of Guillain-Barré syndrome across different regions. J Neuro Sci 344:60–62CrossRefGoogle Scholar
  11. 11.
    Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065CrossRefGoogle Scholar
  12. 12.
    Barret KE, Scott Boitano SMB, Brooks HL (2009) Ganong’s review of medical physiology. McGraw-Hill Medical, LondonGoogle Scholar
  13. 13.
    Steptoe A, Vogele C (1990) Cardiac baroreflex function during postural change assessed using non-invasive spontaneous sequence analysis in young men. Cardiovasc Res 24:627–632CrossRefPubMedGoogle Scholar
  14. 14.
    Parati G, Di Rienzo M, Bertinieri G, Pomidossi G, Casadei R, Groppelli A et al (1988) Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension 12:214–222CrossRefPubMedGoogle Scholar
  15. 15.
    Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27(suppl):21–24CrossRefGoogle Scholar
  16. 16.
    Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14:1103–1109CrossRefPubMedGoogle Scholar
  17. 17.
    Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group (1997) Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 349(9047):225–230CrossRefGoogle Scholar
  18. 18.
    Shahrizaila N, Goh KJ, Kokubun N, Abdullah S, Yuki N (2011) Serial nerve conduction studies provide insight into the pathophysiology of Guillain-Barré and Fisher syndromes. J Neurol Sci 309:26–30CrossRefPubMedGoogle Scholar
  19. 19.
    Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW et al (1995) Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597–605CrossRefPubMedGoogle Scholar
  20. 20.
    Hadden RDM, Cornblath DR, Hughes RAC, Zilasek J, Hartung HP, Toyka KV et al (1998) Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 44:780–788CrossRefPubMedGoogle Scholar
  21. 21.
    Shahani BT, Day TJ, Cros D, Khalil N, Kneebone CS (1990) RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy. Arch Neurol 47:659–664CrossRefPubMedGoogle Scholar
  22. 22.
    Wieling W (1992) Non-invasive continuous recording of heart rate and blood pressure in the evaluation of neurocardiovascular control. In: Bannister R, Mathias CJ (eds) Autonomic failure. A textbook of clinical disorders of the autonomic nervous system, 3rd edn. Oxford University Press, New York, pp 291–311Google Scholar
  23. 23.
    Flachenecker P, Mullges W, Wermuth P, Hartung HP, Reiners K (1996) Eyeball pressure testing in the evaluation of serious bradyarrhythmias in Guillain-Barré syndrome. Neurology 47:102–108CrossRefPubMedGoogle Scholar
  24. 24.
    Freeman R, Wieling W, Axelrod FB et al (2011) Consensus statement on the definition of orthostatic hypotension, neutrally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69–72CrossRefPubMedGoogle Scholar
  25. 25.
    Fagius J, Karhuvaara S, Sundlöf G (1989) The cold pressor test: effects on sympathetic nerve activity in human muscle and skin nerve fascicles. Acta Physiol Scand 137(3):325–334CrossRefPubMedGoogle Scholar
  26. 26.
    Nunan D, Sandercock GRH, Brodie DA (2010) A quantitative systemic review of normal values for short-term heart rate variability in healthy adults. Pacing Clin Electrophysiol 33:1407–1417CrossRefPubMedGoogle Scholar
  27. 27.
    Agelink MW, Malessa R, Baumann B, Majewski T, Akila F, Zeit T et al (2001) Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res 11:99–108CrossRefPubMedGoogle Scholar
  28. 28.
    Kardos A, Watterich G, de Menezes R, Csanády M, Casadei B, Rudas L (2001) Determinants of spontaneous baroreflex sensitivity in a healthy working population. Hypertension 37:911–916CrossRefPubMedGoogle Scholar
  29. 29.
    Ropper H, Wijdicks EFM, Shahani BT (1990) Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome. Arch Neurol 47:881–887CrossRefPubMedGoogle Scholar
  30. 30.
    Taly AB, Arunodaya GR, Rao S (1995) Sympathetic skin response in Guillain-Barré syndrome. Clin Auton Res 5:215–220CrossRefPubMedGoogle Scholar
  31. 31.
    Drory VE, Korczyn AD (1993) Sympathetic skin response: age effect. Neurology 43:1818–1820CrossRefPubMedGoogle Scholar
  32. 32.
    Asahina M, Kuwabara S, Suzuki A, Hattori T (2002) Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome. Acta Neurol Scand 105:44–50CrossRefPubMedGoogle Scholar
  33. 33.
    Zochodne DW (1994) Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve 17:1145–1155CrossRefPubMedGoogle Scholar
  34. 34.
    Hund EF, Schuchardt V, Ropper AH (1994) Acute inflammatory polyneuropathy (Guillain-Barré syndrome). In: Hacke W (ed) Neurocritical care. Springer, Berlin, pp 774–787Google Scholar
  35. 35.
    Arnason BG, Soliven B (1993) Acute inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW et al (eds) Peripheral neuropathy, 3rd edn. WB Saunders, Philadelphia, pp 1437–1497Google Scholar
  36. 36.
    Anandan C, Khuder SA, Koffman BM (2017) Prevalence of autonomic dysfunction in hospitalized patients with Guillain-Barré syndrome. Muscle Nerve 56:331–333CrossRefPubMedGoogle Scholar
  37. 37.
    Pfeiffer G, Schiller B, Kruse J, Netzer J (1999) Indicator of dysautonomia in severe Guillain-Barré syndrome. J Neurol 246:1015–1022CrossRefPubMedGoogle Scholar
  38. 38.
    Flachenecker P, Wermuth P, Hartung HP, Reiners K (1997) Quantitative assessment of cardiovascular autonomic function in Guillain-Barré syndrome. Ann Neurol 42:171–179CrossRefPubMedGoogle Scholar
  39. 39.
    Flachenecker P, Hartung HP, Reiners K (1997) Power spectrum analysis of heart rate variability in Guillain-Barré syndrome. A longitudinal study. Brain 120:1885–1894Google Scholar
  40. 40.
    Yerdelen D, Erol T, Karatas M (2010) Selective autonomic screening in Guillain-Barré syndrome. Neurol India 58:398–402CrossRefPubMedGoogle Scholar
  41. 41.
    Tuck RR, McLeod JG (1981) Autonomic dysfunction in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 44:983–990CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Therapeutics and Technology Assessment Subcommittee (1996) Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 46:873–880Google Scholar
  43. 43.
    Harms M (2011) Inpatient management of Guillain-Barré syndrome. Neurohospitalist 1(2):78–84CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Flachenecker P, Lem K, Müllges W, Reiners K (2000) Detection of serious bradyarrhythmias in Guillain-Barré syndrome: sensitivity and specificity of the 24-hour heart rate power spectrum. Clin Auton Res 10:185–191CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Cheng-Yin Tan
    • 1
  • Nortina Shahrizaila
    • 1
  • Kee-Ying Yeoh
    • 1
  • Khean-Jin Goh
    • 1
  • Maw-Pin Tan
    • 2
  1. 1.Division of Neurology, Department of Medicine, Faculty of MedicineUniversity of MalayaKuala LumpurMalaysia
  2. 2.Division of Geriatric Medicine, Department of Medicine, Faculty of MedicineUniversity of MalayaKuala LumpurMalaysia

Personalised recommendations